Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Universita Politecnica Delle Marche currently has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This active matter is assigned to 1 distinct examiner and 1 distinct art unit. The data indicates that the university's current patent prosecution is concentrated in this single technical field, with no other active matters reported.
SVEIVEN, MICHAEL CAMERON is the busiest examiner for the portfolio, currently overseeing 1 pending office action. The presence of 1 distinct art unit shows that the university's biotechnology is being evaluated by a single specialized division. This individual handles the 1 pending office action for the portfolio.
For a practitioner, this concentration means that the prosecution strategy is focused on the 1 distinct examiner. There are no other active cases or different art units to coordinate, allowing for a direct approach. The university's immediate goals in Biotechnology & Pharmaceuticals are tied to the outcome of this single matter, making the interaction with the assigned examiner a primary focus.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SVEIVEN, MICHAEL CAMERON | 1 | 37.5% | +47.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18260882 | FIELD EFFECT TRANSISTOR (FET) BIOSENSOR FOR DETECTION OF VIRAL PARTICLES | SVEIVEN, MICHAEL CAMERON | 34d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18260882 | FIELD EFFECT TRANSISTOR (FET) BIOSENSOR FOR DETECTION OF VIRAL PARTICLES | SVEIVEN, MICHAEL CAMERON | 34d |
| Art Unit | Apps |
|---|---|
| 1678 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18260882 | FIELD EFFECT TRANSISTOR (FET) BIOSENSOR FOR DETECTION OF VIRAL PARTICLES | SVEIVEN, MICHAEL CAMERON | 1678 | §102§103§112 | Non-Final OA | 34d | Pending | Jul 10, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial